Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
Author:
Publisher
BMJ
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology
Reference5 articles.
1. Available: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Risikogruppen.html
2. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
3. Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York;Haberman;N Engl J Med,2020
4. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia;Quinti;J Allergy Clin Immunol,2020
5. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Die Deutsche Gesellschaft für Rheumatologie und Klinische Immunologie e. V. (DGRh) und die COVID-19-Pandemie;Zeitschrift für Rheumatologie;2024-07-15
2. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25
3. Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting;Vaccines;2024-06-18
4. Das deutsche COVID-19-Rheumaregister;Zeitschrift für Rheumatologie;2024-05-30
5. The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population—A comparison of two German registries;Frontiers in Medicine;2024-03-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3